There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.
India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are revolutionising India’s medical future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback